Summary Tarsa Therapeutics Inc (Tarsa) is a developer of therapies for the treatment and prevention of osteoporosis and other bone related diseases.The company develops calcitonin tablet TBRIA, an oral formulation of calcitonin, a peptide hormone that inhibits bone resorption, which is used for the treatment of postmenopausal osteoporosis in women at least five years post menopause.
The company also offers osteoporosis treatment and osteoporosis prevention clinical programs.It develops patented oral delivery technologies underlying the development of osteoporosis.
Tarsa is headquartered in Philadelphia, Pennsylvania, the US.
Tarsa Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Drugs In Development, 2021 Summary Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Placental growth factor is a protein encoded by the PGF gene. Placental growth factor (PGF)...
Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 188.8.131.52) - Drugs In Development, 2021 Summary According to the recently published report ’Coagulation Factor XI - Drugs In Development, 2021’; Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 184.108.40.206) pipeline...
230 pages •
By Asia Market Information & Development Company
• Aug 2021
China’s demand for Heparin has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
291 pages •
By Asia Market Information & Development Company
• Aug 2021
China’s demand for Caps and Closures has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
Orexin Receptor Type 2 - Drugs In Development, 2021 Summary According to the recently published report ’Orexin Receptor Type 2 - Drugs In Development, 2021’; Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) pipeline Target constitutes close to 16 molecules. Out of which approximately...
120 pages •
By Infiniti Research Limited
• Jul 2021
Global Cleanroom Consumables Market 2021-2025
The analyst has been monitoring the cleanroom consumables market and it is poised to grow by USD 4.61 bn during 2021-2025, progressing at a CAGR of 6.06% during the forecast period. Our report on the cleanroom consumables market provides a holistic analysis, market size and...
The Europe medical refrigerators market is expected to reach US$ 1,563.77 million in 2028 from US$ 1,080.06 million in 2021; it is estimated to grow at a CAGR of 5.4% from 2021 to 2028. The market growth is attributed to factors such as increasing demand for blood and blood components, technological advancements in medical refrigerators,...
Real-world data and real-world evidence are used to monitor the post-market safety and adverse events of drugs.The monitoring of this data assists in making regulatory decisions. The healthcare community is using RWE and RWD to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice. The...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.